Loading…

Trough (C0) and 2‐hour postdose (C2) cyclosporine monitoring in patients with moderate‐to‐severe psoriasis

Saved in:

Bibliographic Details
Published in:	Journal of the European Academy of Dermatology and Venereology 2019-05, Vol.33 (5), p.e215-e217
Main Authors:	Herrero‐Moyano, M., Pedraz, J., Muñoz‐Aceituno, E., Chicharro, P., Reolid, A., Lara, S., Daudén, E.
Format:	Article
Language:	English
Subjects:	Administration, Oral Adult Cyclosporine - blood Cyclosporine - pharmacokinetics Cyclosporine - therapeutic use Drug Monitoring Female Humans Immunosuppressive Agents - blood Immunosuppressive Agents - pharmacokinetics Immunosuppressive Agents - therapeutic use Male Memory, Episodic Psoriasis - blood Psoriasis - drug therapy Severity of Illness Index
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!